FDA says Smart Women's Choice birth control cream is an unapproved new drug sold without FDA approval.
What happened
FDA reviewed the company's website from February to April 2021 and its Facebook and Instagram pages. FDA found the company took orders for Smart Women’s Choice and made claims that it prevents pregnancy and is safe and effective birth control. FDA said those claims make the product a drug and that it is an unapproved new drug.
What FDA found
The product is intended to prevent pregnancy and affect body function, so FDA treats it as a drug.
section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)FDA considers the product a new drug because it is not generally recognized as safe and effective for its claimed uses.
section 201(p) of the FD&C Act, 21 U.S.C. 321(p)The company sells the new drug without an FDA-approved application.
section 505(a) of the FD&C Act, 21 U.S.C. 355(a)The company introduces or delivers the product for introduction into interstate commerce, which is prohibited for this unapproved new drug.
section 301(d) of the FD&C Act, 21 U.S.C. 331(d)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the steps taken to fix the violations and prevent recurrence, with supporting documents. If it cannot finish in that time, it must explain why and give a completion date.
Who should pay attention
- women considering non-hormonal birth control
- retailers and distributors that sell contraceptive products
- companies making similar birth-control claims online
This is a summary. Read the original letter on fda.gov.